Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dugen Pharma, officially known as Dügen İlaç Sanayi ve Ticaret, is a Turkish pharmaceutical company specializing in the development and commercialization of generic drugs. Founded in 1994 and based in Istanbul, the company provides a broad range of therapeutic products focusing on the central nervous system, cardiovascular health, and gastroenterology. Dugen Pharma is recognized for its commitment to providing affordable healthcare solutions within the Turkish market while adhering to international Good Manufacturing Practices (GMP). Its portfolio includes well-known generic versions of essential medicines, such as fluoxetine and atorvastatin. The company operates as a private entity, maintaining a strong distribution network across Turkey.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dugen Pharma.